Ledger.Open graph →
SEC Form D · filed December 30, 2024

Marker Therapeutics, Inc

Offering
$16.1M
Sold
$16.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

R. Llc · Houston, TXExec · DirectorKatherine Okorafor · Houston, TXExec · DirectorJill J. Cress · Rye, NYDirectorYan Wang · Billerica, MADirectorRobert I. Taormina · Celebration, FLDirectorPat D. Wills · Dublin, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗